Measure #3 of the transition of care objective under stage 2 of meaningful use requires eligible professionals and eligible hospitals to either:
• Conduct one or more successful electronic exchanges of a summary of care document with a recipient who has an EHR designed by a different EHR developer than that of its own.
OR
• Conduct one or more successful tests with the CMS-designated “test EHR” during the EHR reporting period.
CMS and the ONC have worked together to identify a minimum set of technical capabilities that need to be in place for an EHR to be designated a “test EHR.” Eligible professionals and hospitals that want to pursue the second method for meeting measure #3 of the transition of care objective can do so using these CMS-designated “test EHRs.”
CMS and the ONC call on the EHR developer and vendor community to participate in the program to become CMS-designated “test EHRs.”
More Articles on CMS:
CMS: Hospital Readmissions Down to 17.8%
CMS Touts Lower Healthcare Spending, Readmissions Under PPACA
CMS Releases FAQs on Medicaid RACs
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
